New YouTube Policy Targets Cancer Misinformation
Online misinformation is harming cancer patients. YouTube has been part of the problem, but a new policy might change that.
Bladder Cancer News
BLADDER CANCER ADVISOR
Bladder Cancer News
Radiotherapy for Prostate Cancer Linked to Higher Risk of Bladder and Lung Cancer
Prostate cancer patients treated with radiotherapy have a higher risk of developing and dying from bladder cancer or lung cancer than patients treated with radical prostatectomy alone, a study suggests.
Cisplatin Shortage Nearly Resolved; Supplies of Carboplatin, Methotrexate Increasing
The US supply of cisplatin is nearly restored, and shortages of carboplatin and methotrexate have been alleviated, the government says.
Ranitidine Does Not Increase the Risk of Cancer, Study Suggests
A meta-analysis suggests that ranitidine does not pose an increased risk of cancer when compared to other histamine-2 receptor antagonists.
Oncologists Receive More EHR Messages Than Other HCPs but Spend Less Time in EHRs
A new study suggests that electronic health records could be better tailored to meet the specific needs of oncologists.
Cancer Deaths Increased During the First 2 Years of the COVID-19 Pandemic
Cancer deaths increased during the first 2 years of the COVID-19 pandemic in the United States, a population-based study suggests.
Breakthroughs in Targeted Therapy, Immunotherapy Reduce Cancer Deaths
Breakthroughs in targeted therapy and immunotherapy are partly responsible for the recent decline in US cancer deaths, according to the AACR Cancer Progress Report 2023.
Global Incidence of Early-Onset Cancers Rose 80% From 1990 to 2019
New data suggest that, from 1990 to 2019, the global incidence of early-onset cancer increased by nearly 80%, and the rate of early-onset cancer deaths increased by nearly 30%.
Adding Ipilimumab to Nivolumab Doesn’t Provide Meaningful Benefit, Researchers Say
Adding ipilimumab to treatment with nivolumab does not provide a clinically meaningful benefit in patients with certain cancers, a meta-analysis suggests.
Cancer Patients With ICI-Induced Acute Pancreatitis May Require Imaging, Monitoring
Cancer patients with ICI-induced acute pancreatitis may require abdominal imaging for diagnosis and monitoring for exocrine pancreatic insufficiency.
Cancer Patients Have Higher Prevalence of Myocardial Infarction as Cause of Chest Pain
Patients with current or past cancer have a higher prevalence of acute myocardial infarction as the cause of chest pain than patients without cancer.
Cancer Patients More Likely to Die From Early Omicron Variants of SARS-CoV-2
Cancer patients were more likely to die from the BA.1 and BA.2 omicron variants of SARS-CoV-2 than from wild-type SARS-CoV-2, data suggest.
Antibody-Drug Conjugates Pose Risk of Ocular Adverse Effects
Pharmaceutical experts review ocular adverse effects related to antibody-drug conjugates.
Administrative Tasks Required to Pay for Cancer Care May Prompt Nonadherence
The burden of administrative tasks required to pay for cancer care is associated with nonadherence to care, a new study suggests.
Managing Ocular Side Effects of Immune Checkpoint Inhibitors
Ocular side effects of immune checkpoint inhibitors are considered rare but may be underreported.
Mask Mandates Have Kept One Cancer Center Free From COVID-19. Others Have Lifted Masking Requirements Despite Patient Concerns
Some cancer centers have lifted mask mandates that were intended to protect patients from COVID-19, despite patient concerns.
Perioperative Durvalumab Deemed Promising for Muscle-Invasive Urothelial Carcinoma
Adding durvalumab to standard treatment for resectable, muscle-invasive urothelial carcinoma produces promising outcomes, according to researchers.
Cancer Survivors With Functional Disabilities Have Higher Health Care Costs
Cancer survivors with functional disabilities have higher health care usage and medical costs than survivors without disabilities, data suggest.
Deaths Among Cancer Patients Increased During the First 2 Years of the COVID-19 Pandemic
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
Systemic Therapies May Increase Risk of VTE in Patients With Cancer and COVID-19
Researchers found a higher risk of VTE in patients with cancer and COVID-19 who were receiving systemic cancer therapies.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...